To further elucidate the mechanism of synergy between β-lap and PD-L1 blockade, we investigated tumor-infiltrated immune cells in the tumor microenvironment by flow cytometry analysis and tracked antigen-specific T cells in the MC38-OVA tumor model. The gene discussed is CD274; the disease is neoplasm.